@Article{,
AUTHOR = {Miguel Rodriguez-Homs, Brett Wiesen, Mona Rizeq, Colin Randau, Granville L. Lloyd},
TITLE = {Solitary brain metastasis after recurrent adenocarcinoma of the prostate},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {28},
YEAR = {2021},
NUMBER = {1},
PAGES = {10565--10567},
URL = {http://www.techscience.com/CJU/v28n1/60237},
ISSN = {1488-5581},
ABSTRACT = {Prostate cancer is rarely metastatic to visceral organs, and 
even less commonly to the brain. Recent data suggests 
brain metastasis from prostatic adenocarcinoma occur in 
0.16% of patients, and almost universally in the setting 
of very high-volume disease. We present a man with an abruptly symptomatic brain lesion that developed at a 
PSA value of 1.5 ng/mL with no other known metastatic 
disease and required emergent neurosurgical resection. 
The patient had been initially treated with radiotherapy 
for Grade Group 4 prostate cancer in 2005 with a long 
period of PSA suppression.},
DOI = {}
}